Drug Administration Schedule
"Drug Administration Schedule" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience.
| Descriptor ID |
D004334
|
| MeSH Number(s) |
E02.319.283
|
| Concept/Terms |
Drug Administration Schedule- Drug Administration Schedule
- Administration Schedule, Drug
- Administration Schedules, Drug
- Drug Administration Schedules
- Schedule, Drug Administration
- Schedules, Drug Administration
|
Below are MeSH descriptors whose meaning is more general than "Drug Administration Schedule".
Below are MeSH descriptors whose meaning is more specific than "Drug Administration Schedule".
This graph shows the total number of publications written about "Drug Administration Schedule" by people in this website by year, and whether "Drug Administration Schedule" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 13 | 13 |
| 1996 | 0 | 13 | 13 |
| 1997 | 0 | 10 | 10 |
| 1998 | 0 | 13 | 13 |
| 1999 | 0 | 12 | 12 |
| 2000 | 0 | 12 | 12 |
| 2001 | 0 | 17 | 17 |
| 2002 | 0 | 11 | 11 |
| 2003 | 0 | 21 | 21 |
| 2004 | 0 | 14 | 14 |
| 2005 | 0 | 23 | 23 |
| 2006 | 0 | 29 | 29 |
| 2007 | 0 | 36 | 36 |
| 2008 | 0 | 26 | 26 |
| 2009 | 0 | 23 | 23 |
| 2010 | 0 | 25 | 25 |
| 2011 | 0 | 32 | 32 |
| 2012 | 0 | 29 | 29 |
| 2013 | 0 | 28 | 28 |
| 2014 | 0 | 23 | 23 |
| 2015 | 0 | 19 | 19 |
| 2016 | 0 | 19 | 19 |
| 2017 | 0 | 24 | 24 |
| 2018 | 0 | 30 | 30 |
| 2019 | 0 | 18 | 18 |
| 2020 | 0 | 13 | 13 |
| 2021 | 0 | 8 | 8 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug Administration Schedule" by people in Profiles.
-
Comparative Effectiveness of Less vs. More Frequent Hydrocortisone Dosing in Septic Shock. Crit Care Explor. 2025 Sep 01; 7(9):e1316.
-
Evaluation of coadministration schedules of rA1M for kidney protection after administration of 177Lu-octreotide. Radiat Prot Dosimetry. 2025 Aug 26; 201(13-14):995-1005.
-
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20?years in sub-Saharan Africa. Contemp Clin Trials. 2025 Aug; 155:107963.
-
Completion, Safety and Tolerability of Once-weekly Isoniazid and Rifapentine for Tuberculosis Infection by Children and Adolescents. Pediatr Infect Dis J. 2025 Feb 14; 44(8):755-758.
-
Lurbinectedin is an effective alternative to platinum rechallenge and may restore platinum sensitivity in patients with sensitive relapsed small cell lung cancer. Expert Rev Anticancer Ther. 2025 Jan; 25(1):27-40.
-
A weekly low-dose regimen of decitabine and venetoclax is efficacious and less myelotoxic in a racially diverse cohort. Blood. 2024 Nov 28; 144(22):2360-2363.
-
Abbreviated ticagrelor based dual antiplatelet therapy in acute coronary syndrome: A systematic review and meta-analysis. Cardiovasc Revasc Med. 2025 Jun; 75:64-70.
-
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6. J Am Acad Dermatol. 2025 Jan; 92(1):68-77.
-
Safety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma. Neuro Oncol. 2024 May 03; 26(Supplement_2):S155-S164.
-
Impact of oral vancomycin treatment duration on rate of Clostridioides difficile recurrence in patients requiring concurrent systemic antibiotics. Infect Control Hosp Epidemiol. 2024 Jun; 45(6):717-725.